Cargando…

Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study

BACKGROUND: To investigate whether or not coadministration of tacrolimus (TAC) with prednisolone (PSL) can produce a beneficial effect in the treatment of polymyositis/ dermatomyositis (PM/DM). METHODS: We reviewed medical records of 32 PM/DM patients who had been admitted to our hospital, and abstr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimojima, Yasuhiro, Ishii, Wataru, Matsuda, Masayuki, Tazawa, Ko-ichi, Ikeda, Shu-ichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565925/ https://www.ncbi.nlm.nih.gov/pubmed/23173570 http://dx.doi.org/10.1186/1471-2474-13-228

Ejemplares similares

Coadministration of Cyclosporin A with Prednisolone in Acute Interstitial Pneumonia Complicating Polymyositis/Dermatomyositis
por: Shimojima, Yasuhiro, et al.
Publicado: (2012)

Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission
por: Shimojima, Yasuhiro, et al.
Publicado: (2012)

Nutrition and Polymyositis and Dermatomyositis
por: Loell, Ingela, et al.
Publicado: (2008)

Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis
por: Oddis, Chester V., et al.
Publicado: (2022)

Treatment of refractory juvenile dermatomyositis with tacrolimus
por: Hassan, J, et al.
Publicado: (2008)

Adalimumab Monotherapy in a Patient with Psoriatic Arthritis Associated with Chronic Renal Failure on Hemodialysis: A Case Report and Literature Review
por: Shimojima, Yasuhiro, et al.
Publicado: (2012)

Viral Etiology of Polymyositis/Dermatomyositis
por: DENMAN, A.M.
Publicado: (1988)

Subcutaneous Edema in Polymyositis and Dermatomyositis
por: Yoshimi, Ryusuke, et al.
Publicado: (2023)

Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine
por: Schiopu, Elena, et al.
Publicado: (2012)

Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis
por: Hirai, Takuya, et al.
Publicado: (2018)

Polymyositis and dermatomyositis: Disease spectrum and classification
por: Raychaudhuri, Siba P, et al.
Publicado: (2012)

Polymyositis and dermatomyositis – challenges in diagnosis and management
por: Yang, Shu-Han, et al.
Publicado: (2019)

Dermatomyositis and polymyositis in total hip arthroplasty
por: Rosas, Samuel, et al.
Publicado: (2021)

Impact of adding tacrolimus to initial treatment of interstitial pneumonitis in polymyositis/dermatomyositis: a single-arm clinical trial
por: Takada, Kazuki, et al.
Publicado: (2019)

Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series
por: Levine, Todd
Publicado: (2012)

Polymyositis and dermatomyositis as a risk of developing cancer
por: Jakubaszek, Michał, et al.
Publicado: (2015)

Cardiac involvement in polymyositis and dermatomyositis: diagnostic approaches
por: Trybuch, Agnieszka, et al.
Publicado: (2023)

Potential role of autophagy in T-cell survival in polymyositis and dermatomyositis
por: Shu, Xiaoming, et al.
Publicado: (2017)

Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions
por: Silva, Marilda Guimarães, et al.
Publicado: (2018)

STROBE: The correlation of Cyr61, CTGF, and VEGF with polymyositis/dermatomyositis
por: Chai, Ke-Xia, et al.
Publicado: (2018)

Identification of hub biomarkers and immune cell infiltration in polymyositis and dermatomyositis
por: Chen, Si, et al.
Publicado: (2022)

Coadministration of Liraglutide With Tacrolimus in Kidney Transplant Recipients: A Case Series
por: Pinelli, Nicole R., et al.
Publicado: (2013)

Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study
por: Ikeda, Satoshi, et al.
Publicado: (2015)

Disease burden and treatment sequence of polymyositis and dermatomyositis patients in Japan: a real-world evidence study
por: Miyazaki, Celine, et al.
Publicado: (2021)

Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial
por: Miyasaka, Nobuyuki, et al.
Publicado: (2011)

Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan
por: Chen, Yi-Ju, et al.
Publicado: (2010)

Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis
por: Kim, Geun-Tae, et al.
Publicado: (2009)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
por: Sugiyama, Yumiko, et al.
Publicado: (2018)

Upregulation of Interleukin 21 and Interleukin 21 Receptor in Patients with Dermatomyositis and Polymyositis
por: Liu, Tao, et al.
Publicado: (2017)

Epilepsy as a Comorbidity in Polymyositis and Dermatomyositis—A Cross-Sectional Study
por: Nissan, Ella, et al.
Publicado: (2021)

Supervised Physical Therapy and Polymyositis/Dermatomyositis—A Systematic Review of the Literature
por: Corrado, Bruno, et al.
Publicado: (2020)

Clinical Features of Dermatomyositis/Polymyositis with Anti-MDA5 Antibody Positivity
por: Chen, Qiuhe, et al.
Publicado: (2022)

Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis
por: Palmucci, Stefano, et al.
Publicado: (2022)

Serum uric acid is independently associated with hypertension in patients with polymyositis and dermatomyositis
por: liu, mei, et al.
Publicado: (2023)

Different Influences on Tacrolimus Pharmacokinetics by Coadministrations of Zhi Ke and Zhi Shi in Rats
por: Lin, Shiuan-Pey, et al.
Publicado: (2011)

Correction to: Disease burden and treatment sequence of polymyositis and dermatomyositis patients in Japan: a real-world evidence study
por: Miyazaki, Celine, et al.
Publicado: (2022)

HMGB1, a new proinflammatory molecule of interest in polymyositis and dermatomyositis patients
por: Grundtman, C, et al.
Publicado: (2003)

Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis
por: da Cunha, Gilmara Franco, et al.
Publicado: (2013)

Thrombotic Microangiopathy with Polymyositis/Dermatomyositis: Three Case Reports and a Literature Review
por: Yamada, Saeko, et al.
Publicado: (2018)

Increased risk of venous thromboembolism associated with polymyositis and dermatomyositis: a meta-analysis
por: Li, Yanqing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jstiuap813165sm1ndeul4h0p4